Mark Augusti

Directeur Général chez AdvaMed Accel

Profil

Mark A. Augusti is the President, Chief Executive Officer & Director of AdvaMed Accel.
He was previously the President, Chief Executive Officer & Director of ConforMIS, Inc. from 2016 to 2023, and the President & Chief Executive Officer of Bioventus LLC in 2012-2013.
He served as an Independent Director at Hutchinson Technology, Inc. from 2011 to 2012.
From 2014 to 2016, he was the VP, President-Orthopedics & Tissue Technologies at Integra LifeSciences Holdings Corp.
He was also a Vice President at JPMorgan Chase & Co. in 2003.
From 2003 to 2012, he was the President-Biologics & Clinical Therapies at Smith & Nephew plc.
Augusti received his undergraduate degree from Duke University and his MBA from UCLA Anderson School of Management.

Postes actifs de Mark Augusti

Sociétés	Poste	Début
AdvaMed Accel	Directeur Général	-

Anciens postes connus de Mark Augusti

Sociétés	Poste	Fin
CONFORMIS, INC.	Directeur Général	05/09/2023
INTEGRA LIFESCIENCES HOLDINGS CORPORATION	Corporate Officer/Principal	11/11/2016
HUTCHINSON TECHNOLOGY INCORPORATED	Directeur/Membre du Conseil	09/05/2012
SMITH & NEPHEW PLC	Corporate Officer/Principal	01/04/2012
JPMORGAN CHASE & CO.	Corporate Officer/Principal	01/01/2003